Bioanalysis Zone and Bioanalysis journal have this month launched the third edition of The Bioanalysis Glossary, an essential resource for scientists working in bioanalysis and related fields.
Following the success of the second edition, published in 2016, this new edition includes over 40 new terms and an updated section incorporating commonly used equations by bioanalysts across the field.
"The Bioanalysis and Bioanalysis Zone editorial teams are delighted to bring you the third edition of The Bioanalysis Glossary, which we hope continues to be regarded as the definitive resource, particularly for those moving into the field or working within bioanalytical laboratories for the first time," commented Sankeetha Nadarajah, Commissioning Editor of Bioanalysis.
"Ten leading bioanalytical experts from industry and academia have been working closely with the editorial team to provide a comprehensive update of the 2016 edition, reflecting the rapidly evolving and dynamic field of bioanalysis."
It is hoped that the Glossary will continue to aid in the harmonization of terminology used within the community and between companies, universities and individuals.
Senior Editor of Bioanalysis Zone, Naamah Maundrell, said: "As the field continues to change and evolve, it is important that we speak the same technical language. We are delighted to be able to help with this endeavor and provide this unique resource for the bioanalytical community."
Bioanalysis is a MEDLINE-indexed journal covering the latest scientific, technical and regulatory developments relevant to those working on the analysis of xenobiotics and biotics in biological matrices. This is, primarily, bioanalysts working in pharmaceutical research and development, clinical laboratories, clinical toxicologists, forensic toxicologists and sports doping analysts.
About Bioanalysis Zone
Since launching in 2011, Bioanalysis Zone has attracted over 11,000 active members from the global bioanalytical community, representing the pharmaceutical, biotech and CRO industries, along with academia and healthcare. Each month, thousands of members visit the site to read industry news, peer-reviewed research, exclusive interviews, webinars and commentaries. Join the Bioanalysis Zone Twitter and LinkedIn group for updates.
About Future Science Group
Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. FSG's portfolio includes two imprints, Future Science and Future Medicine. In addition to this core publishing business, FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.
The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.